Pediatrix Medical Group, Inc. (MD)
NYSE: MD · IEX Real-Time Price · USD
7.03
-0.08 (-1.13%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for MD stock have an average target of 9.10, with a low estimate of 8.00 and a high estimate of 10. The average target predicts an increase of 29.45% from the current stock price of 7.03.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for MD stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 2 | 3 | 4 | 4 | 4 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Strong Sell → Hold Upgrades $8 | Strong Sell → Hold | Upgrades | $8 | +13.80% | Jun 7, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $10 | Hold | Maintains | $10 | +42.25% | May 15, 2024 |
| Jefferies | Jefferies | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +28.02% | Mar 6, 2024 |
| Mizuho | Mizuho | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +28.02% | Feb 21, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | +42.25% | Feb 21, 2024 |
Financial Forecast
Revenue This Year
2.08B
from 1.99B
Increased by 4.13%
Revenue Next Year
2.12B
from 2.08B
Increased by 2.26%
EPS This Year
1.26
from -0.73
EPS Next Year
1.34
from 1.26
Increased by 6.65%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.2B | 2.3B | 2.3B |
| Avg | 2.1B | 2.1B | 2.2B |
| Low | 1.9B | 1.9B | 2.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 9.0% | 9.2% | 6.4% |
| Avg | 4.1% | 2.3% | 2.4% |
| Low | -3.4% | -8.6% | -6.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.37 | 1.52 | 1.52 | 1.29 |
| Avg | 1.26 | 1.34 | 1.37 | 1.27 |
| Low | 1.08 | 1.19 | 1.24 | 1.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 20.9% | 13.4% | -5.5% |
| Avg | - | 6.6% | 1.8% | -7.3% |
| Low | - | -5.8% | -7.3% | -11.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.